CADENCE PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 15, 2010

Attached files

file filename
10-K - FORM 10-K - CADENCE PHARMACEUTICALS INCd10k.htm
EX-10.35 - 2010 CORPORATE BONUS PLAN - CADENCE PHARMACEUTICALS INCdex1035.htm
EX-32.1 - CERTIFICATION OF CEO AND CFO PURSUANT TO 18.U.S.C. SECTION 1350 - CADENCE PHARMACEUTICALS INCdex321.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A - 14(A) AND 15D-14(A) - CADENCE PHARMACEUTICALS INCdex311.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A - 14(A) AND 15D-14(A) - CADENCE PHARMACEUTICALS INCdex312.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statements on Form S-8 (Nos. 333-163941 and 133-138226) and Form S-3 (Nos. 333-161756, 33-158126 and 333-147721) of Cadence Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated March 15, 2010, with respect to the financial statements of Cadence Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Cadence Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2009.

/s/ Ernst & Young LLP

San Diego, California

March 15, 2010

Stock widget

Investing forum

CADENCE PHARMACEUTICALS INC Reports